Surgery results in greater improvement in weight loss outcomes and weight associated comorbidities compared with non-surgical interventions , regardless of the type of procedures used .
When compared with each other , certain procedures result ed in greater weight loss and improvements in comorbidities than others .
Outcomes were similar between RYGB and sleeve gastrectomy , and both of these procedures had better outcomes than adjustable gastric b and ing .
For people with very high BMI , biliopancreatic diversion with duodenal switch result ed in greater weight loss than RYGB .
Isolated sleeve gastrectomy led to better weight-loss outcomes than adjustable gastric b and ing after three years follow-up .
BACKGROUND Bariatric ( weight loss ) surgery for obesity is considered when other treatments have failed .
The effects of the available bariatric procedures compared with medical management and with each other are uncertain .
This is an up date of a Cochrane review first published in 2003 and most recently up date d in 2009 .
OBJECTIVES To assess the effects of bariatric surgery for overweight and obesity , including the control of comorbidities .
Laparoscopic sleeve gastrectomy for obesity.
Objective To explore efficacy and safety of laparoscopic sleeve gastrectomy for the treatment of obesity . Methods Forty patients underwent laparoscopic sleeve gastrectomy as a treatment option for weight reduction between December 2006 and February 2010.Mean  preoperative body weight (BW),body mass index ( BMI ) and exceed body weight ( EBW ) were(104.2 ±3.3 ) kg,(36.9 ± 1.0 ) kg/m2 and ( 37.8 ±3.0 ) kg , respectively . Outcome data were collected and assessed prospect ively . Results Laparoscopic procedures were completed in all patients , with no conversion to open surgery . The operation time averaged ( 80 ± 18 ) min , and there were no severe postoperative complications . The median postoperative hospital stay was ( 5.5 ± 1.5 ) days . BMI loss was ( 4.3 ± 1.7 ) kg/m2 , ( 7.0 ± 1.9 ) kg/m2,(9.3 ±3.1 ) kg/m2 and ( 10.1 ±3.8 ) kg/m2,respectively , and percentage of EBW loss was 35.0％ ± 13.5％,57.1％ ± 17.7％,74.2％ ±27.2％ , and 81.8％ ±29.4％,respectively , at 1,3,6 , and 12 months following the procedure . Conclusion Laparoscopic sleeve gastrectomy is an effective and safe surgical option for the treatment of obesity with lower BMI .Additional long-term studies are still needed to accurately compare laparoscopic sleeve gastrectomy with other procedures of weight reduction . Key words : Obesity , morbid ; Laparoscopy ;
Surgery results in greater improvement in weight loss outcomes and weight associated comorbidities compared with non-surgical interventions , regardless of the type of procedures used .
When compared with each other , certain procedures result ed in greater weight loss and improvements in comorbidities than others .
Outcomes were similar between RYGB and sleeve gastrectomy , and both of these procedures had better outcomes than adjustable gastric b and ing .
For people with very high BMI , biliopancreatic diversion with duodenal switch result ed in greater weight loss than RYGB .
Isolated sleeve gastrectomy led to better weight-loss outcomes than adjustable gastric b and ing after three years follow-up .
BACKGROUND Bariatric ( weight loss ) surgery for obesity is considered when other treatments have failed .
The effects of the available bariatric procedures compared with medical management and with each other are uncertain .
This is an up date of a Cochrane review first published in 2003 and most recently up date d in 2009 .
OBJECTIVES To assess the effects of bariatric surgery for overweight and obesity , including the control of comorbidities .